Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
What does a Drupal Developer do?
When you begin a search to upgrade your website or CMS, there are loads of options and frameworks which will ultimately mold and give shape to your Digital Experience, what you will eventually become…
|
How to Configure Single Sign On across Multiple Drupal 8 Platforms or Websites ?
What do you mean by Single Sign-On? Why do we use it? Single Sign-On is an authentication service that allows users to use credentials to log in to multiple sites
|
How to ace project delivery?
The need to cut down costs and increase efficiency in operations has become the need of the hour. Technological improvements are driving Digital Transitions and business decisions are becoming the…
|
Why should your vendor be a Digital Experience creator?
Once again we hop on the journey to create a series of articles and this time we take on the challenge to deal with the topic DX - Digital Experience. We know about it but a very few speak about it.…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
